207 related articles for article (PubMed ID: 5792112)
1. [Preparation and use of factor VIII concentrates in hemophilia].
Vilar JM; Ortega F; Martin-Arias DM; Vazquez J; Navarro JL
Sangre (Barc); 1969; 14(1):57-64. PubMed ID: 5792112
[No Abstract] [Full Text] [Related]
2. Recombinant factor VIII in hemophilia A: the Canadian experience.
Blanchette VS
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
[TBL] [Abstract][Full Text] [Related]
3. Supply and need of factor VIII concentrates.
Britten A; Etzel F; Ala F; Carman C; Smit Sibinga C
Haematologia (Budap); 1983; 16(1-4):109-20. PubMed ID: 6434377
[TBL] [Abstract][Full Text] [Related]
4. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
Gaerisch F; Stein P
Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
[TBL] [Abstract][Full Text] [Related]
5. Hemostasis. II. The use of factor VIII concentrates in the therapy of hemophilia.
Davis RB
Nebr State Med J; 1971 Jun; 56(6):219-24. PubMed ID: 4253029
[No Abstract] [Full Text] [Related]
6. [Therapy of hemophilia A with a cryoprecipitated antihemophilic factor].
Ollendorff P
Ugeskr Laeger; 1969 May; 131(20):877-81. PubMed ID: 5795169
[No Abstract] [Full Text] [Related]
7. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
8. [Anti-hemophilia drugs: from cryoprecipitate to factor VIII concentrates of high purity].
Gutsalo AE; Varetskaia TV; Kozulina EP; Papaian LP
Ukr Biokhim Zh (1978); 1995; 67(1):3-13. PubMed ID: 8588250
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C and pasteurised factor VIII and IX concentrates.
Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
[No Abstract] [Full Text] [Related]
10. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
Lange D; Lazerson J
Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
[No Abstract] [Full Text] [Related]
11. Aspects of the management of hemophilia in childhood. Availability of newer concentrates of antihemophilic factor failitates management.
Strauss HS
R I Med J; 1966 Aug; 49(8):466-8. PubMed ID: 5222119
[No Abstract] [Full Text] [Related]
12. Preliminary clinical experience: pharmacokinetics and tolerance of a double-virus-inactivated factor VIII preparation.
Martinowitz U
Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S84-5. PubMed ID: 7495976
[TBL] [Abstract][Full Text] [Related]
13. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
Kuble M; Wegner H; Cron D
Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194
[No Abstract] [Full Text] [Related]
14. High potency factor VIII concentrates.
BMJ; 1991 Oct; 303(6809):1061-2. PubMed ID: 1954471
[No Abstract] [Full Text] [Related]
15. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
[TBL] [Abstract][Full Text] [Related]
16. The clinical use of porcine factor VIII.
Kernoff PB
Prog Clin Biol Res; 1990; 324():47-56. PubMed ID: 2106692
[TBL] [Abstract][Full Text] [Related]
17. Clotting factor concentrated--whither purity?
Thomas DP
Thromb Haemost; 1995 Dec; 74(6):1604-6. PubMed ID: 8772244
[No Abstract] [Full Text] [Related]
18. [Factor VIII concentrates].
Faber JC
Bull Soc Sci Med Grand Duche Luxemb; 1986; 123(2):27-9. PubMed ID: 3100076
[No Abstract] [Full Text] [Related]
19. The treatment of classical hemophilia with factor 8 concentrates.
Waterbury L; Frenkel EP
Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
[No Abstract] [Full Text] [Related]
20. Treatment of hemophilia with factor 8 concentrates.
Dallman PR; Pool JG
N Engl J Med; 1968 Jan; 278(4):199-202. PubMed ID: 5711341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
